Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07519733 · ClinicalTrials.gov registry record
Preoperative Exercise Testing and Perioperative Outcomes
A clinical trial, sponsored by Yale University.
- Recruiting
- Registry status
- 992
- Enrollment target
NCT07519733: Recruiting study, sponsored by Yale University.
NCT07519733 is a clinical trial that is actively recruiting participants, run by Yale University. The registered enrollment target is 992 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07519733 is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 992 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn whether results from a brief exercise test done before surgery can help identify adults who may be more likely to have problems after moderate- to high-risk noncardiac surgery. The study includes adults older than 45 years who are seen in a pre-surgical evaluation clinic and complete submaximal cardiopulmonary exercise testing, or smCPET, as part of their usual clinical care. The main questions it aims to answer are: Are smCPET measurements linked with early problems after surgery? Are smCPET measurements linked with later problems after surgery, including complications within 30 and 60 days, longer hospital stay, and death? Can smCPET add useful information to standard preoperative risk assessment? Researchers will observe and analyze information collected during routine care. No extra exercise testing or treatment will be done for research. Participants will: * Complete routine preoperative evaluation in the Yale Pre-Surgical Evaluation Clinic. * Undergo smCPET if it is ordered as part of standard clinical care. * Allow researchers to collect information from the medical record and from the exercise test for the study repository, if they agree to participate. The study will collect de-identified information about each participant's health before surgery, exercise test results, details about the surgery and hospital stay, and problems that happen after surgery. This may include age, sex, body mass index, other medical conditions, routine lab and imaging results, heart rate, blood pressure, oxygen levels, smCPET measures such as peak oxygen uptake, anaerobic threshold, and breathing efficiency, and early and late postoperative outcomes. Researchers will look at short-term and later outcomes after surgery. These include problems identified during the hospital stay, such as heart, lung, kidney, nerve, blood, wound, and pain-related complications, as well as complications within 30 and 60 days after surgery. Researc
Primary Outcome
Composite Cardiovascular death, acute heart failure, cardiac arrythymias, perioperative myocardia infarction/injury in the 30 days after surgical procedure.
Interventions
- DIAGNOSTIC_TEST Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 992 participants |
| Start Date | 2025-07-23 |
| Est. Completion | 2028-07-30 |
What NCT07519733 shows while recruiting
NCT07519733 is an observational study that tracks outcomes without assigning an intervention. The registered 992 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinic is the first listed.
NCT07519733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07519733 about?
NCT07519733 is a clinical study titled "Preoperative Exercise Testing and Perioperative Outcomes". The goal of this observational study is to learn whether results from a brief exercise test done before surgery can help identify adults who may be more likely to have problems after moderate- to high-risk noncardiac surgery. The study includes adults older than 45 years who are seen in a pre-surgic...
What is the current status of trial NCT07519733?
This trial is currently recruiting. The enrollment target is 992 participants. The study started on 2025-07-23. Estimated completion is 2028-07-30.
What interventions are being tested in trial NCT07519733?
The interventions under investigation include: Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinic (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07519733?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05987241 · 992 participants · Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
- NCT05437575 · 994 participants · Phase 3
Prehospital Analgesia INtervention Trial (PAIN)
- NCT06671704 · 994 participants · NA
GC-PRO Intervention
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI